Access these electronic applications to complete action items or handle research-related submissions.
Pre-proposal Announcement: Strategic Research Appointments for Faculty
The Office of the President and the Office of the Vice President for Research are pleased to sponsor a new program to fund appointments for faculty designed to significantly advance our research efforts under the UTA strategic plan themes: Health and the Human Condition, Sustainable Urban Communities, Global Environmental Impact, and Data-Driven Discovery. The Strategic Research Appointments for Faculty (SRAF) program will enable faculty to spend time at another institution (or institutions) to conduct research while expanding their knowledge & expertise and building key partnerships. As the ability to effectively compete for major research programs often benefit significantly from or may even require partnerships with other institutions, the SRAF program creates an important new way to help faculty develop research collaborations for UTA while carrying out their research and developing new research proposals.
These appointments, which will be awarded on a competitive basis, provide support for one semester at full salary to enable a faculty member to spend time at another research institution. Other research institutions include national/government labs, research universities, or corporate labs. In some circumstances, appointments can be at one half salary for both academic semesters. Awards under the SRAF program will be limited to faculty members who 1) have served full-time as assistant, associate, or full professors on the UT Arlington faculty for at least two consecutive academic years, and 2) have earned tenure by the time the appointment commences. Funds will be provided to cover instructional needs during the appointment period.
The call for proposals should be available December 4th and the web site for proposal submissions is intended to be open between December 15th and January 25th. Proposals will be reviewed by a committee reporting to the Vice President for Research, who will then make recommendations to the President of the University. The overriding principle upon which proposals will be evaluated is the potential for achievement surpassing the normal responsibilities of a faculty member, which will be judged based on:
The quality of the proposed research and the likely impact of this work under one or more of the UTA strategic themes
The ability for this appointment to enhance research expertise and capabilities
How this appointment will build or expand important partnership(s) for creating additional sponsored research programs at UTA.
How this appointment will be used to develop research proposals and enhance our competitiveness for extramural research funding (The appointment will need to led to a proposal for extramural funding)
Dr. Duane Dimos
Vice President for Research
The University of Texas at Arlington
Research Administration Procedures Update
UTA Research Administration has updated its communication procedure for managing research-related agreements. This new policy will clarify and promote efficiency with prospective and recurring sponsors and others, and identify more easily which unit is responsible for agreements by type.
Immunology expert and serial entrepreneur Jon Weidanz appointed UTA associate vice president for research
The University of Texas at Arlington is pleased to announce that Dr. Jon Weidanz, founding chairman of the department of immunotherapeutics and biotechnology of Texas Tech University Health Sciences Center (TTUHSC), has been appointed associate vice president for research.
Dr. Weidanz is also a serial entrepreneur who founded four private biotechnology companies with technologies developed from his academic laboratory.
As chairman of the department of immunotherapeutics and biotechnology at TTUHSC, Dr. Weidanz provided the critical leadership to establish and grow new research programs and mentor faculty to successfully compete for extramural funding from the National Institutes of Health, Department of Defense and Cancer Prevention Research Institute of Texas.
He also founded and served as executive director and chief scientist of Experimmune, a public private partnership and immunology-focused contract research organization designed to provide third-party validation services, product development and due diligence to support TTUHSC, small to large biotechnology companies, big pharmaceutical companies and investment groups. Experimmune has generated of significant revenue in its first two years.
Dr. Weidanz said “I am excited to be joining UTA at a time when the university is undergoing significant growth in research. I am especially excited about the unique opportunity to lead the university’s effort to expand research programs in the life sciences and health-related fields.”
“I look forward to having a key role in strategic development, pursuing funding opportunities to support the diverse work of the university and constructing partnerships and collaborations that further the goals of UTA,” he added. “I envision playing a key leadership role as both a senior administrator and researcher in the University's campaign toward achieving national and international research recognition.”
Dr. Weidanz will report to Dr. Duane Dimos, a former vice president of Sandia Laboratories who joined UTA in April 2015 as vice president for research with the mission to expand the University’s research and entrepreneurial enterprise and foster commercialization of University intellectual property.
Dr. Dimos said “With his tremendous experience and leadership in health research, Dr. Weidanz will play a key leadership role at UTA for expanding our research under the strategic theme of ‘Health and the Human Condition’. His experience in the corporate world is also extremely valuable to us as we look to expand our commercialization capacities, assist faculty and student innovation and entrepreneurship initiatives and attract venture capital and businesses to UTA.”
In addition to his new administrative position, Dr. Weidanz also has been appointed as a professor in the Department of Biology. As a leading researcher in immunology, immunotherapy, and immunodiagnostics, Dr. Weidanz will receive support through the University of Texas System Science and Technology Acquisition and Retention, or STARS program. The program provides additional startup funding needed to attract scholars with exceptional records of research, teaching, and creative activity.
Dr. Morteza Khaledi, dean of the UTA College of Science said “Dr. Weidanz is clearly an accomplished professor and researcher with a strong track record of scholarship in his field. We are excited to have Jon join the College of Science and know he will add to the critical mass of our college and biology program as we do more in the area of health sciences.”
Dr. Weidanz is also currently serving as associate dean of the TTUHSC Graduate School for Biomedical Sciences, director of the TTUHSC graduate program in biotechnology and adjunct professor in the department of internal medicine of the TTUHSC School of Medicine.
He graduated with a bachelor’s degree in biology from West Virginia University, followed by a master’s in public health and doctorate in molecular biology and immunology from the University of Alabama at Birmingham.